Evaluating randomized trials of screening

Journal of General Internal Medicine

Volumn 12, Issue 2, 1997, Pages 118-124

  Welch, H Gilbert ^a,b   Black, William C ^b,c  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; HUMAN; MEDICAL RESEARCH; OUTCOMES RESEARCH; RANDOMIZATION; REVIEW; SCREENING;

BREAST NEOPLASMS; COLONIC NEOPLASMS; EVALUATION STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 0030892222     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.1997.00017.x     Document Type: Review

References (20)

1. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, Md: Williams and Wilkins; 1996.
2. Wilfond BS, Nolan K. National policy development for the clinical application of genetic diagnostic technologies: lessons from cystic fibrosis. JAMA. 1993;270:2948-54.
3. Russell LB. Educated guesses: making policy about medical screening tests. Berkeley, Calif: The Regents of the University of California: 1994:128.
4. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993;328:1237-43.
5. Cochrane AL, Holland WW. Validation of screening procedures. Br Med Bull. 1971;27:1-8.
6. Lee JM. Screening and informed consent. N Engl J Med. 1993; 328:438-40.
7. Guyett GH, Sackett DL, Cook DJ. User's guide to the medical literature. How to use an article about therapy or prevention. JAMA. 1993;270:2598-2601.
8. Fontana R. Screening for lung cancer. In: Miller A, ed. Screening for Cancer, Orlando, Fla: Academic Press; 1985;377-95.
9. Sanderson D. Lung cancer screening: The Mayo Study. Chest. 1986;(4 suppl):324S.
10. Shapiro S, Venet W, Strax P, Venet L. Periodic Screening for Breast Cancer: The Health Insurance Plan Project and Its Sequelae 1963-1986. Baltimore, Md: John Hopkins University Press; 1988.
11. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365-71.
12. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson IC. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996;275:913-8.
13. Strauss G, Gleason R, Sugarbaker D. Screening for lung cancer re-examined. A reinterpretation of the Mayo Lung Project randomized trial on lung cancer screening. Chest. 1993;(4 suppl):337S-41S.
14. Strauss G, Gleason R, Sugarbaker D. Chest X-ray screening improves outcome in lung cancer. A reappraisal of randomized trials on lung cancer screening. Chest. 1995;(6 suppl):270S-9S.
15. Black WC, Welch HG. Screening for disease. Am J Roentgenol. 1997;168:3-11.
16. Morrison AS. Screening in Chronic Disease. 2nd ed. New York, NY: Oxford University Press; 1992:254.
17. Kubick A, Parkin D, Khlat M, Erban J, Polak J, Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high risk males in Czechoslovakia. Int J Cancer. 1990;45:26-33.
18. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ. 1988;297:943-8.
19. Naylor C, Chen E, Strauss B. Does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med. 1992;117:916-21.
20. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol and mortality: a quantitative review of primary prevention trials. BMJ. 1990;301:309-14.